Name: Bio-Rad Laboratories, Inc. (BIO.B) Financial Statements
Creator: FinSpry

Bio-Rad Laboratories Income Statement Analysis

Revenue, earnings, and profit margins in billions USD

Scale:

Scroll to see more

Bio-Rad Laboratories, Inc. income statement - Annual data in billions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Revenue & Gross Profit
Revenue	2.57	2.67	2.80	2.92	2.55
Cost of Revenue	1.19	1.24	1.23	1.26	1.11
Gross Profit	1.38	1.43	1.57	1.66	1.44
Operating Expenses
Research & Development	0.30	0.25	0.26	0.25	0.22
Selling, General & Administrative	0.81	0.84	0.83	0.85	0.80
Operating Expenses	1.11	1.09	1.09	1.10	1.02
Operating Income	0.27	0.34	0.48	0.56	0.42
Other Income/Expense
Interest Income	0.08	0.10	0.06	0.02	0.02
Interest Expense	0.05	0.05	0.04	0.00	-0.02
Other Income/Expense	-2.64	-1.24	-5.20	0.00	0.00
Income
Income Before Tax	-2.34	-0.85	-4.70	5.45	4.92
Income Tax Expense	-0.50	-0.21	-1.08	1.19	1.10
Net Income	-1.84	-0.64	-3.63	4.25	3.81
Net Income - Continuous Operations	-1.84	-0.64	-3.63	4.25	0.00
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00	0.00
EBITDA	-2.14	-0.65	-4.53	0.70	0.56
EBIT	-2.29	-0.80	-4.67	0.56	0.42
Depreciation & Amortization	0.15	0.15	0.14	0.14	0.14
Earnings Per Share
Basic EPS	-65.00	-22.00	-122.00	143.00	128.00
Diluted EPS	-65.00	-22.00	-122.00	141.00	126.00
Basic Shares Outstanding	0.03	0.03	0.03	0.03	0.03
Diluted Shares Outstanding	0.03	0.03	0.03	0.03	0.03